Abstract
Extramedullary manifestation (EM) in patients with acute myeloid leukemia (AML) occurs frequently at diagnosis and more frequently at relapse in patients after allogeneic hematopoietic stem cell transplantation (HCT). While EM AML is clinically thought to represent a more aggressive form of AML, genetic analyses have shown that EM AML might harbor any AML-associated cytogenetic or genetic abnormalities that are observed in AML without EM. In this chapter also, the diagnostic approach to patients with EM AML is depicted and therapeutic scenarios are described discussing management options for patients with EM AML.
The difficulty in interpreting chloroma, in assigning to it its proper role within the categories of leukemia, arises from the fact that it belongs to that group of borderland cases which lies between genuine neoplasms and leukemias.
Heinrich Lehndorff, *1877 Vienna—†1965 New York
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alakel N, Stolzel F, Mohr B, Kramer M, Oelschlagel U, Rollig C et al (2017) Symptomatic central nervous system involvement in adult patients with acute myeloid leukemia. Cancer Manag Res 9:97–102
Alvarez P, Navascues CA, Ordieres C, Pipa M, Vega IF, Granero P et al (2011) Granulocytic sarcoma of the small bowel, greater omentum and peritoneum associated with a CBFbeta/MYH11 fusion and inv(16) (p13q22): a case report. Int Arch Med 4(1):3
Ando T, Mitani N, Matsunaga K, Nakazora T, Gondo T, Yujiri T et al (2010) Gemtuzumab ozogamicin therapy for isolated extramedullary AML relapse after allogeneic hematopoietic stem-cell transplantation. Tohoku J Exp Med 220(2):121–126
Ansari-Lari MA, Yang CF, Tinawi-Aljundi R, Cooper L, Long P, Allan RH et al (2004) FLT3 mutations in myeloid sarcoma. Br J Haematol 126(6):785–791
Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391–2405
Arber DA, Borowitz MJ, Cessna M, Etzell J, Foucar K, Hasserjian RP et al (2017) Initial diagnostic workup of acute leukemia: guideline from the College of American Pathologists and the American Society of Hematology. Arch Pathol Lab Med 141(10):1342–1393
Avni B, Koren-Michowitz M (2011) Myeloid sarcoma: current approach and therapeutic options. Ther Adv Hematol 2(5):309–316
Bakst R, Yahalom J (2011) Radiation therapy for leukemia cutis. Pract Radiat Oncol 1(3):182–187
Bakst RL, Tallman MS, Douer D, Yahalom J (2011) How I treat extramedullary acute myeloid leukemia. Blood 118(14):3785–3793
Bakst R, Wolden S, Yahalom J (2012) Radiation therapy for chloroma (granulocytic sarcoma). Int J Radiat Oncol Biol Phys 82(5):1816–1822
Byrd JC, Weiss RB (1994) Recurrent granulocytic sarcoma. An unusual variation of acute myelogenous leukemia associated with 8;21 chromosomal translocation and blast expression of the neural cell adhesion molecule. Cancer 73(8):2107–2112
Byrd JC, Edenfield WJ, Shields DJ, Dawson NA (1995) Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J Clin Oncol 13(7):1800–1816
Caraffini V, Perfler B, Berg JL, Uhl B, Schauer S, Kashofer K et al (2018) Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltration. Blood 131(7):826–830
Cheng CL, Li CC, Hou HA, Fang WQ, Chang CH, Lin CT et al (2015) Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults. BMC Cancer 15:344
Cohen PR, Talpaz M, Kurzrock R (1988) Malignancy-associated Sweet’s syndrome: review of the world literature. J Clin Oncol 6(12):1887–1897
Cornelissen JJ, Gratwohl A, Schlenk RF, Sierra J, Bornhauser M, Juliusson G et al (2012) The European LeukemiaNet AML working party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach. Nat Rev Clin Oncol 9(10):579–590
Davids MS, Kim HT, Bachireddy P, Costello C, Liguori R, Savell A et al (2016) Ipilimumab for patients with relapse after allogeneic transplantation. N Engl J Med 375(2):143–153
Deeb G, Baer MR, Gaile DP, Sait SN, Barcos M, Wetzler M et al (2005) Genomic profiling of myeloid sarcoma by array comparative genomic hybridization. Genes Chromosomes Cancer 44(4):373–383
Dohner K, Schlenk RF, Habdank M, Scholl C, Rucker FG, Corbacioglu A et al (2005) Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations. Blood 106(12):3740–3746
Falini B, Lenze D, Hasserjian R, Coupland S, Jaehne D, Soupir C et al (2007) Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. Leukemia 21(7):1566–1570
Fernandez HF, Sun Z, Litzow MR, Luger SM, Paietta E, Racevskis J et al (2019) Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900. Haematologica 104(4):e147–ee50
Ganzel C, Manola J, Douer D, Rowe JM, Fernandez HF, Paietta EM et al (2016) Extramedullary disease in adult acute myeloid leukemia is common but lacks independent significance: analysis of patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008. J Clin Oncol 34(29):3544–3553
Ge L, Ye F, Mao X, Chen J, Sun A, Zhu X et al (2014) Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia. Biol Blood Marrow Transplant 20(7):1040–1047
Harris AC, Kitko CL, Couriel DR, Braun TM, Choi SW, Magenau J et al (2013) Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes. Haematologica 98(2):179–184
Karlin L, Itti E, Pautas C, Rachid M, Bories D, Cordonnier C et al (2006) PET-imaging as a useful tool for early detection of the relapse site in the management of primary myeloid sarcoma. Haematologica 91(12 Suppl):ECR54
Kashofer K, Gornicec M, Lind K, Caraffini V, Schauer S, Beham-Schmid C et al (2018) Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing. Leuk Lymphoma 59(2):501–504
King C (1934) A case of chloroma with orbital involvement locally benefited by X-ray therapy. Trans Am Ophthalmol Soc 32:340–353
Kuenzle K, Taverna C, Steinert HC (2002) Detection of extramedullary infiltrates in acute myelogenous leukemia with whole-body positron emission tomography and 2-deoxy-2-[18F]-fluoro-D-glucose. Mol Imaging Biol 4(2):179–183
Larson SM, Graff KS, Tretner IH, Zager RF, Henderson EA, Johnston GS (1972) Positive gallium 677 photoscan in myeloblastoma. JAMA 222(3):321–323
Lehndorff (1910) Ergebnisse der inneren Medizin und Kinderheilkunde, p 221
Li Z, Stolzel F, Onel K, Sukhanova M, Mirza MK, Yap KL et al (2015) Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma. Leukemia 29(10):2113–2116
Mantzarides M, Bonardel G, Fagot T, Gontier E, Soret M, Revel TD et al (2008) Granulocytic sarcomas evaluated with F-18-fluorodeoxyglucose PET. Clin Nucl Med 33(2):115–117
Meis JM, Butler JJ, Osborne BM, Manning JT (1986) Granulocytic sarcoma in nonleukemic patients. Cancer 58(12):2697–2709
Mirza MK, Sukhanova M, Stolzel F, Onel K, Larson RA, Stock W et al (2014) Genomic aberrations in myeloid sarcoma without blood or bone marrow involvement: characterization of formalin-fixed paraffin-embedded samples by chromosomal microarrays. Leuk Res 38(9):1091–1096
Montesinos P, Diaz-Mediavilla J, Deben G, Prates V, Tormo M, Rubio V et al (2009) Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis. Haematologica 94(9):1242–1249
Neumann M, Blau IW, Burmeister T, Tietze-Buerger C, Blau O, Gerbitz A et al (2011) Intrathecal application of donor lymphocytes in leukemic meningeosis after allogeneic stem cell transplantation. Ann Hematol 90(8):911–916
O’Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA et al (2017) Acute myeloid leukemia, version 3.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 15(7):926–957
Ohanian M, Faderl S, Ravandi F, Pemmaraju N, Garcia-Manero G, Cortes J et al (2013) Is acute myeloid leukemia a liquid tumor? Int J Cancer 133(3):534–543
Owonikoko T, Agha M, Balassanian R, Smith R, Raptis A (2007) Gemtuzumab therapy for isolated extramedullary AML relapse following allogeneic stem-cell transplant. Nat Clin Pract Oncol 4(8):491–495
Piccaluga PP, Martinelli G, Rondoni M, Malagola M, Gaitani S, Isidori A et al (2004) Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas. Leuk Lymphoma 45(9):1791–1795
Pileri SA, Ascani S, Cox MC, Campidelli C, Bacci F, Piccioli M et al (2007) Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia 21(2):340–350
Pui MH, Fletcher BD, Langston JW (1994) Granulocytic sarcoma in childhood leukemia: imaging features. Radiology 190(3):698–702
Shem-Tov N, Saraceni F, Danylesko I, Shouval R, Yerushalmi R, Nagler A et al (2017) Isolated extramedullary relapse of acute leukemia after allogeneic stem cell transplantation: different kinetics and better prognosis than systemic relapse. Biol Blood Marrow Transplant 23(7):1087–1094
Shihadeh F, Reed V, Faderl S, Medeiros LJ, Mazloom A, Hadziahmetovic M et al (2012) Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease. Cancer 118(1):112–117
Shimizu H, Saitoh T, Hatsumi N, Takada S, Handa H, Jimbo T et al (2013) Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia. Leuk Res 37(11):1477–1481
Solh M, DeFor TE, Weisdorf DJ, Kaufman DS (2012) Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse. Biol Blood Marrow Transplant 18(1):106–112
Solh M, Solomon S, Morris L, Holland K, Bashey A (2016) Extramedullary acute myelogenous leukemia. Blood Rev 30(5):333–339
Stolzel F, Rollig C, Radke J, Mohr B, Platzbecker U, Bornhauser M et al (2011) (1)(8)F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia. Haematologica 96(10):1552–1556
Stolzel F, Hackmann K, Kuithan F, Mohr B, Fussel M, Oelschlagel U et al (2012) Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation. Transplantation 93(7):744–749
Stolzel F, Luer T, Lock S, Parmentier S, Kuithan F, Kramer M et al (2020) The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET/CT: final results from the prospective PETAML trial. Haematologica 105(6):1552–1558
Tsimberidou AM, Kantarjian HM, Wen S, Keating MJ, O’Brien S, Brandt M et al (2008) Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia. Cancer 113(6):1370–1378
Ueda K, Ichikawa M, Takahashi M, Momose T, Ohtomo K, Kurokawa M (2010) FDG-PET is effective in the detection of granulocytic sarcoma in patients with myeloid malignancy. Leuk Res 34(9):1239–1241
Vago L (2019) Clonal evolution and immune evasion in posttransplantation relapses. Hematology Am Soc Hematol Educ Program 2019(1):610–616
Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5):937–951
Vega-Ruiz A, Faderl S, Estrov Z, Pierce S, Cortes J, Kantarjian H et al (2009) Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience. Int J Hematol 89(4):489–496
von den Driesch P (1994) Sweet’s syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 31(4):535–556; quiz 57–60
Xavier SG, Fagundes EM, Hassan R, Bacchi C, Conchon M, Tabak DG et al (2003) Granulocytic sarcoma of the small intestine with CBFbeta/MYH11 fusion gene: report of an aleukaemic case and review of the literature. Leuk Res 27(11):1063–1066
Yamauchi K, Yasuda M (2002) Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer 94(6):1739–1746
Yoshihara S, Ando T, Ogawa H (2012) Extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: an easily overlooked but significant pattern of relapse. Biol Blood Marrow Transplant 18(12):1800–1807
Zhang XH, Zhang R, Li Y (2010) Granulocytic sarcoma of abdomen in acute myeloid leukemia patient with inv(16) and t(6;17) abnormal chromosome: case report and review of literature. Leuk Res 34(7):958–961
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Stölzel, F. (2021). Special Clinical Scenarios: Extramedullary Disease. In: Röllig, C., Ossenkoppele, G.J. (eds) Acute Myeloid Leukemia . Hematologic Malignancies. Springer, Cham. https://doi.org/10.1007/978-3-030-72676-8_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-72676-8_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-72675-1
Online ISBN: 978-3-030-72676-8
eBook Packages: MedicineMedicine (R0)